Candida auris outbreak: Mortality, interventions and cost of sustaining control
34 patients acquired the organism including 8 with blood stream infections. Clinical infection was significantly associated with prolonged hospital stay, haemodialysis and antifungal therapy. Variable susceptibility to amphotericin and the triazoles was seen and isolates clustered with the South Asian strains. No significant difference was detected in the survival probabilities of C .auris BSI compared to other candidemias. Outbreak control cost in excess of £ 1 million and £58,000/month during the subsequent year.Effective Surveillance
Join the AMR Insights Ambassador Network today!
Connect to over 550 AMR professionals and students in 60 countries!